Associations between changes in habitual sleep duration and lower self-rated health among COVID-19 survivors: findings from a survey across 16 countries/regions.

Coronavirus infections Fatigue Health status indicators Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Sleep wake disorders

Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
28 Nov 2023
Historique:
received: 13 07 2023
accepted: 18 11 2023
medline: 30 11 2023
pubmed: 29 11 2023
entrez: 29 11 2023
Statut: epublish

Résumé

Self-rated health (SRH) is widely recognized as a clinically significant predictor of subsequent mortality risk. Although COVID-19 may impair SRH, this relationship has not been extensively examined. The present study aimed to examine the correlation between habitual sleep duration, changes in sleep duration after infection, and SRH in subjects who have experienced SARS-CoV-2 infection. Participants from 16 countries participated in the International COVID Sleep Study-II (ICOSS-II) online survey in 2021. A total of 10,794 of these participants were included in the analysis, including 1,509 COVID-19 individuals (who reported that they had tested positive for COVID-19). SRH was evaluated using a 0-100 linear visual analog scale. Habitual sleep durations of < 6 h and > 9 h were defined as short and long habitual sleep duration, respectively. Changes in habitual sleep duration after infection of ≤ -2 h and ≥ 1 h were defined as decreased or increased, respectively. Participants with COVID-19 had lower SRH scores than non-infected participants, and those with more severe COVID-19 had a tendency towards even lower SRH scores. In a multivariate regression analysis of participants who had experienced COVID-19, both decreased and increased habitual sleep duration after infection were significantly associated with lower SRH after controlling for sleep quality (β = -0.056 and -0.058, respectively, both p < 0.05); however, associations between current short or long habitual sleep duration and SRH were negligible. Multinomial logistic regression analysis showed that decreased habitual sleep duration was significantly related to increased fatigue (odds ratio [OR] = 1.824, p < 0.01), shortness of breath (OR = 1.725, p < 0.05), diarrhea/nausea/vomiting (OR = 2.636, p < 0.01), and hallucinations (OR = 5.091, p < 0.05), while increased habitual sleep duration was significantly related to increased fatigue (OR = 1.900, p < 0.01). Changes in habitual sleep duration following SARS-CoV-2 infection were associated with lower SRH. Decreased or increased habitual sleep duration might have a bidirectional relation with post-COVID-19 symptoms. Further research is needed to better understand the mechanisms underlying these relationships for in order to improve SRH in individuals with COVID-19.

Sections du résumé

BACKGROUND BACKGROUND
Self-rated health (SRH) is widely recognized as a clinically significant predictor of subsequent mortality risk. Although COVID-19 may impair SRH, this relationship has not been extensively examined. The present study aimed to examine the correlation between habitual sleep duration, changes in sleep duration after infection, and SRH in subjects who have experienced SARS-CoV-2 infection.
METHODS METHODS
Participants from 16 countries participated in the International COVID Sleep Study-II (ICOSS-II) online survey in 2021. A total of 10,794 of these participants were included in the analysis, including 1,509 COVID-19 individuals (who reported that they had tested positive for COVID-19). SRH was evaluated using a 0-100 linear visual analog scale. Habitual sleep durations of < 6 h and > 9 h were defined as short and long habitual sleep duration, respectively. Changes in habitual sleep duration after infection of ≤ -2 h and ≥ 1 h were defined as decreased or increased, respectively.
RESULTS RESULTS
Participants with COVID-19 had lower SRH scores than non-infected participants, and those with more severe COVID-19 had a tendency towards even lower SRH scores. In a multivariate regression analysis of participants who had experienced COVID-19, both decreased and increased habitual sleep duration after infection were significantly associated with lower SRH after controlling for sleep quality (β = -0.056 and -0.058, respectively, both p < 0.05); however, associations between current short or long habitual sleep duration and SRH were negligible. Multinomial logistic regression analysis showed that decreased habitual sleep duration was significantly related to increased fatigue (odds ratio [OR] = 1.824, p < 0.01), shortness of breath (OR = 1.725, p < 0.05), diarrhea/nausea/vomiting (OR = 2.636, p < 0.01), and hallucinations (OR = 5.091, p < 0.05), while increased habitual sleep duration was significantly related to increased fatigue (OR = 1.900, p < 0.01).
CONCLUSIONS CONCLUSIONS
Changes in habitual sleep duration following SARS-CoV-2 infection were associated with lower SRH. Decreased or increased habitual sleep duration might have a bidirectional relation with post-COVID-19 symptoms. Further research is needed to better understand the mechanisms underlying these relationships for in order to improve SRH in individuals with COVID-19.

Identifiants

pubmed: 38017498
doi: 10.1186/s12889-023-17258-3
pii: 10.1186/s12889-023-17258-3
pmc: PMC10683140
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2352

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 22K15778

Informations de copyright

© 2023. The Author(s).

Références

Int J Physiol Pathophysiol Pharmacol. 2021 Aug 15;13(4):117-125
pubmed: 34540132
Sci Rep. 2022 May 25;12(1):8801
pubmed: 35614108
Econ Anal Policy. 2020 Dec;68:17-28
pubmed: 32843816
Intern Emerg Med. 2022 Aug;17(5):1491-1501
pubmed: 35235130
Nat Rev Microbiol. 2023 Mar;21(3):133-146
pubmed: 36639608
Int J Environ Res Public Health. 2021 Apr 01;18(7):
pubmed: 33916019
J Immigr Minor Health. 2021 Jun;23(3):583-590
pubmed: 32691277
J Psychosom Res. 2020 Sep;136:110186
pubmed: 32682159
J Am Geriatr Soc. 1997 Aug;45(8):954-8
pubmed: 9256848
Biopsychosoc Med. 2022 Oct 23;16(1):21
pubmed: 36274177
Nat Sci Sleep. 2022 Jan 24;14:93-108
pubmed: 35115852
EXCLI J. 2022 Aug 16;21:1084-1098
pubmed: 36320806
PLoS One. 2015 May 11;10(5):e0126844
pubmed: 25961874
J Clin Sleep Med. 2012 Dec 15;8(6):719-28
pubmed: 23243408
Ann Am Thorac Soc. 2021 Jun;18(6):997-1003
pubmed: 33413026
J Health Soc Behav. 1997 Mar;38(1):21-37
pubmed: 9097506
J Sleep Res. 2023 Jun;32(3):e13767
pubmed: 36317491
J Sleep Res. 2021 Feb;30(1):e13206
pubmed: 33179820
J Sleep Res. 2022 Aug;31(4):e13542
pubmed: 34964184
Prim Health Care Res Dev. 2022 Nov 10;23:e69
pubmed: 36352492
Sleep Med Rev. 2005 Oct;9(5):355-64
pubmed: 16102986
J Intern Med. 2023 Feb;293(2):246-258
pubmed: 36478477
Soc Sci Med. 2009 Aug;69(3):307-16
pubmed: 19520474
Prev Chronic Dis. 2015 Aug 20;12:E133
pubmed: 26292064
Behav Med. 2023 Apr-Jun;49(2):162-171
pubmed: 34791993
Med Sci Sports Exerc. 1997 Jan;29(1):45-57
pubmed: 9000155
Nat Commun. 2022 Oct 12;13(1):5663
pubmed: 36224173
Lancet Infect Dis. 2022 Apr;22(4):e102-e107
pubmed: 34951953
Sleep. 2020 Nov 12;43(11):
pubmed: 32409833
PLoS One. 2021 Aug 26;16(8):e0256142
pubmed: 34437579
J Occup Environ Med. 2023 Jan 1;65(1):e1-e3
pubmed: 36240747
Sleep Med Rev. 2018 Jun;39:25-36
pubmed: 28890167
Sleep Med. 2011 Apr;12(4):346-50
pubmed: 21388876
Curr Sleep Med Rep. 2022;8(3):42-49
pubmed: 35911079
Scand J Caring Sci. 2011 Dec;25(4):780-6
pubmed: 21564153
Ann Med. 2001 Jul;33(5):337-43
pubmed: 11491192
Front Neurol. 2018 Oct 31;9:922
pubmed: 30429823
Brain Behav Immun. 2007 Feb;21(2):153-60
pubmed: 17088043
Medicina (Kaunas). 2021 Apr 26;57(5):
pubmed: 33925784
Sleep. 2021 Mar 12;44(3):
pubmed: 33538311
BMC Psychiatry. 2020 Nov 23;20(1):549
pubmed: 33228615
Lancet. 2022 Sep 24;400(10357):1033-1046
pubmed: 36115367
Intern Med J. 2023 Oct;53(10):1783-1789
pubmed: 36043439
Int J Environ Res Public Health. 2021 Aug 25;18(17):
pubmed: 34501523
Nat Sci Sleep. 2021 Jun 28;13:933-966
pubmed: 34234598
Curr Pharm Des. 2008;14(32):3408-16
pubmed: 19075717
EClinicalMedicine. 2021 May 24;36:100899
pubmed: 34036253
EClinicalMedicine. 2021 Jun;36:100916
pubmed: 34131640
Psychol Bull. 2012 Jan;138(1):77-101
pubmed: 21967449
Sci Rep. 2021 Mar 17;11(1):6139
pubmed: 33731775
Sleep Med Rev. 2022 Dec;66:101709
pubmed: 36401976
Scand J Prim Health Care. 2018 Sep;36(3):317-322
pubmed: 30139280
J Immunol Res. 2015;2015:678164
pubmed: 26417606
Res Soc Stratif Mobil. 2021 Oct;75:100640
pubmed: 34385741
Sleep Med. 2021 Dec;88:262-266
pubmed: 34801824
Int J Environ Res Public Health. 2021 Apr 19;18(8):
pubmed: 33921852
Nature. 2022 Feb;602(7898):574-577
pubmed: 35194212
Sleep Med. 2020 Dec;76:80-85
pubmed: 33120132
J Clin Sleep Med. 2013 Oct 15;9(10):1057-64
pubmed: 24127150
J Clin Sleep Med. 2017 Jul 15;13(7):899-904
pubmed: 28502281
Sleep. 2004 Nov 1;27(7):1255-73
pubmed: 15586779
Sleep Med Rev. 2007 Oct;11(5):341-60
pubmed: 17625932
Arch Intern Med. 2006 Sep 18;166(16):1689-92
pubmed: 16983045
Sleep. 2011 Sep 01;34(9):1173-7
pubmed: 21886354
J Sleep Res. 2009 Jun;18(2):148-58
pubmed: 19645960
J Gen Intern Med. 2006 Mar;21(3):267-75
pubmed: 16336622
Sleep Health. 2015 Mar;1(1):40-43
pubmed: 29073412
Pain Res Manag. 2018 Nov 4;2018:5801510
pubmed: 30533166
Arch Public Health. 2020 Feb 03;78:6
pubmed: 32025299
Ann Neurol. 2013 Jun;73(6):785-94
pubmed: 23846792
Sleep Med. 2017 Apr;32:246-256
pubmed: 27743803
J Racial Ethn Health Disparities. 2022 Apr;9(2):462-477
pubmed: 33544329
PLoS One. 2020 Aug 21;15(8):e0219647
pubmed: 32822339
Front Psychiatry. 2021 Mar 30;12:625973
pubmed: 33859579

Auteurs

Kentaro Matsui (K)

Department of Clinical Laboratory, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.

Frances Chung (F)

Department of Anesthesiology and Pain Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada.

Adrijana Koscec Bjelajac (AK)

Institute for Medical Research and Occupational Health, Zagreb, Croatia.

Ilona Merikanto (I)

SleepWell Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Orton Orthopaedics Hospital, Helsinki, Finland.

Maria Korman (M)

Department of Occupational Therapy, Faculty of Health Sciences, Ariel University, Ariel, Israel.

Sérgio Mota-Rolim (S)

Brain Institute, Physiology and Behavior Department, and Onofre Lopes University Hospital, Federal University of Rio Grande do Norte, Natal, Brazil.

Ana Suely Cunha (AS)

Medical College, Potiguar University, Natal, Brazil.

Bjørn Bjorvatn (B)

Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Norwegian Competence Center for Sleep Disorders, Haukeland University Hospital, Bergen, Norway.

Pei Xue (P)

Department of Pharmaceutical Biosciences, Molecular Neuropharmacology, Uppsala University, Uppsala, Sweden.

Christian Benedict (C)

Department of Pharmaceutical Biosciences, Molecular Neuropharmacology, Uppsala University, Uppsala, Sweden.

Charles M Morin (CM)

Centre de recherche CERVO/Brain Research Center, École de psychologie, Université Laval, Quebec City Quebec, Canada.

Colin A Espie (CA)

Sir Jules Thorn Sleep and Circadian Neuroscience Institute, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.

Anne-Marie Landtblom (AM)

Department of Medical Sciences, Neurology, Uppsala University, Uppsala, Sweden.
Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.

Thomas Penzel (T)

Sleep Medicine Center, Charite University Hospital Berlin, Berlin, Germany.

Luigi De Gennaro (L)

Department of Psychology, Sapienza University of Rome, Roma, Lazio, Italy.
IRCCS Fondazione Santa Lucia, Roma, Italy.

Brigitte Holzinger (B)

Institute for Consciousness and Dream Research; Medical University of Vienna, Postgraduate Sleep Coaching, WienVienna, Austria.

Harald Hrubos-Strøm (H)

Department of Otorhinolaryngology, Akershus University Hospital, Lørenskog, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Damien Leger (D)

VIFASOM (EA 7331 Vigilance Fatigue Sommeil et Santé Publique), Université Paris Cité, Paris, France.
APHP, Hôtel-Dieu, Centre du Sommeil et de la Vigilance, Paris, France.

Courtney J Bolstad (CJ)

Department of Psychology, Mississippi State University, Mississippi State, MS, USA.
South Texas Veterans Health Care System, San Antonio, Texas, USA.

Michael R Nadorff (MR)

Department of Psychology, Mississippi State University, Mississippi State, MS, USA.

Giuseppe Plazzi (G)

IRCCS Istituto Delle Scienze Neurologiche di Bologna, Bologna, Italy.
Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Catia Reis (C)

Católica Research Centre for Psychological - Family and Social Wellbeing, Universidade Católica Portuguesa, Lisbon, Portugal.
Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina de Lisboa, Universidade de Lisboa, Lisboa, Portugal.
Instituto de Saúde Ambiental, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.

Ngan Yin Chan (NY)

Li Chiu Kong Family Sleep Assessment Unit, Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.

Yun Kwok Wing (YK)

Li Chiu Kong Family Sleep Assessment Unit, Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.

Juliana Yordanova (J)

Institute of Neurobiology, Bulgarian Academy of Sciences, Sofia, Bulgaria.

Yves Dauvilliers (Y)

Sleep-Wake Disorders Center, Department of Neurology, Gui-de-Chauliac Hospital, Institute for Neurosciences of Montpellier INM, INSERM, University of Montpellier, Montpellier, France.

Markku Partinen (M)

Department of Clinical Neurosciences, University of Helsinki Clinicum Unit, Helsinki, Finland.
Helsinki Sleep Clinic, Terveystalo Healthcare Services, Helsinki, Finland.

Yuichi Inoue (Y)

Japan Somnology Center, Institute of Neuropsychiatry, Tokyo, Japan. inoue@somnology.com.
Department of Somnology, Tokyo Medical University, Tokyo, Japan. inoue@somnology.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH